Status:
COMPLETED
The Impact of Continuous Transcutaneous CO2 (TCCO2) Monitoring in Extremely Low Birth Weight (ELBW) Infants
Lead Sponsor:
Rambam Health Care Campus
Conditions:
ELBW - Extremely Low Birth Weight Infant
IVH- Intraventricular Hemorrhage
Eligibility:
All Genders
Up to 24 years
Brief Summary
An observational study comparing outcomes of Extremely Low Birth Weight (ELBW) infants that were monitored with non-invasive Transcutaneous CO2 (TCCO2) monitor to infants that were not monitored by TC...
Eligibility Criteria
Inclusion
- ELBW infants Need of respiratory support
Exclusion
- Parental refusal IVH before study entry chromosomal abnormalities congenital central nervous system (CNS) abnormalities
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT03477708
Start Date
January 1 2018
End Date
April 1 2022
Last Update
April 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel